首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1609868

日本免疫組織化學市場報告（按產品（抗體、設備、試劑、試劑盒）、應用（診斷、藥物測試）、最終用戶（醫院和診斷實驗室、研究機構等）和地區 2025-2033

Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年日本免疫組化市場規模達1.777IMARC Group美元。與年齡相關的疾病的日益流行、強大的醫療基礎設施的存在、對個人化醫療的認知不斷增強、政府對醫學研究的資金和支持不斷增加，以及病理學領域的最新進展是推動市場的一些關鍵因素。

免疫組織化學 (IHC) 是一種診斷和研究技術，利用抗原抗體相互作用的原理來識別組織樣本中的特定蛋白質、抗原或細胞。它涉及將抗體應用到裝有組織切片的玻片上，然後與感興趣的抗原反應，並使用顯色或螢光染料進行可視化。免疫組織化學有多種類型，包括顯色、螢光和多重。它由幾個組件組成，例如一抗、二抗、檢測系統和底物。 IHC 提供多種功能，包括高特異性、靈敏度以及準確定位細胞成分的能力。它廣泛應用於腫瘤學、神經生物學、傳染病和組織形態發生。免疫組織化學也應用於法醫學、環境研究和藥物測試。它具有成本效益、速度和處理大樣本量的能力。除此之外，免疫組織化學以其微創性、提供原位分析的能力、定量能力以及與高通量篩選自動化技術的無縫整合而聞名。

日本免疫組織化學市場趨勢：

由於日本阿茲海默症和癌症等與年齡相關的疾病日益流行，對免疫組織化學的需求不斷成長，推動了市場的成長。此外，強大的醫療保健基礎設施支援採用 IHC 等複雜的診斷技術，正在推動市場成長。此外，人們對個人化醫療的認知不斷增強，這增加了對標靶診斷技術的需求，從而促進了市場的成長。此外，政府對醫學研究的資金和支持不斷增加也促進了市場的成長。除此之外，生活方式疾病的發生率不斷上升，需要早期和精確的診斷，這對市場成長產生了積極影響。此外，病理學領域的最新進展使 IHC 變得更加重要，特別是對於基於組織的診斷，從而推動了市場的成長。同時，學術界和工業界之間不斷加強的合作促進了 IHC 的研發 (R&D)，正在推動市場成長。與此一致的是，日本 IHC 流程的自動化程度不斷提高，減少了人工錯誤並提高了通量，正在加速市場成長。此外，IHC 在藥物開發和測試中的廣泛應用開闢了新的擴張途徑，也是另一個成長誘導因素。除此之外，影像技術的快速進步增強了 IHC 的能力，也刺激了市場的成長。此外，日本不斷成長的醫療保健支出允許整合先進的診斷技術，這也推動了全國市場的成長。

日本免疫組織化學市場細分：

產品見解：

抗體
一抗
二抗
裝置
玻片染色系統
組織微陣列
組織處理系統
玻片掃描儀
其他
試劑
組織學染色
封閉血清和試劑
顯色底物
固定試劑
穩定劑
有機溶劑
蛋白水解酶
稀釋劑
套件

應用見解：

診斷
癌症
傳染病
心血管疾病
自體免疫疾病
糖尿病
腎臟病
藥物檢測

最終使用者見解：

醫院和診斷實驗室
研究所
其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

到目前為止，日本免疫組織化學市場的表現如何，未來幾年又會如何表現？
COVID-19 對日本免疫組織化學市場有何影響？
日本免疫組化市場的產品細分如何？
日本免疫組化市場在應用上的細分如何？
日本免疫組織化學市場的最終用戶細分如何？
日本免疫組織化學市場價值鏈的各個階段是什麼？
日本免疫組化的關鍵促進因素和挑戰是什麼？
日本免疫組化市場的結構如何？
日本免疫組化市場的競爭程度如何？

本報告回答的關鍵問題：

到目前為止，日本免疫組織化學市場的表現如何，未來幾年又會如何表現？
COVID-19 對日本免疫組織化學市場有何影響？
日本免疫組化市場的產品細分如何？
日本免疫組化市場在應用上的細分如何？
日本免疫組織化學市場的最終用戶細分如何？
日本免疫組織化學市場價值鏈的各個階段是什麼？
日本免疫組化的關鍵促進因素和挑戰是什麼？
日本免疫組化市場的結構如何？
日本免疫組化市場的競爭程度如何？

抗體
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 一抗
  - 二抗
- 市場預測（2025-2033）
裝置
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 玻片染色系統
  - 組織微陣列
  - 組織處理系統
  - 玻片掃描儀
  - 其他
- 市場預測（2025-2033）
試劑
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 組織學染色
  - 封閉血清和試劑
  - 顯色底物
  - 固定試劑
  - 穩定劑
  - 有機溶劑
  - 蛋白水解酶
  - 稀釋劑
- 市場預測（2025-2033）
套件
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 7 章：日本免疫組織化學市場 - 細分：按應用分類

診斷
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場區隔
  - 癌症
  - 傳染病
  - 心血管疾病
  - 自體免疫疾病
  - 糖尿病
  - 腎臟病
- 市場預測（2025-2033）
藥物檢測
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 8 章：日本免疫組織化學市場 - 細分：按最終用戶分類

醫院和診斷實驗室
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
研究所
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 9 章：日本免疫組織化學市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 10 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本免疫組織化學市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 12 章：附錄

簡介目錄

Product Code: SR112024A18972

Japan immunohistochemistry market size reached USD 177.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 321.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.1% during 2025-2033. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Organic Solvents
Proteolytic Enzymes
Diluents
Kits

Application Insights:

Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Nephrological Diseases
Drug Testing

End User Insights:

Hospitals and Diagnostic Laboratories
Research Institutes
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan immunohistochemistry market?
What is the breakup of the Japan immunohistochemistry market on the basis of product?
What is the breakup of the Japan immunohistochemistry market on the basis of application?
What is the breakup of the Japan immunohistochemistry market on the basis of end user?
What are the various stages in the value chain of the Japan immunohistochemistry market?
What are the key driving factors and challenges in the Japan immunohistochemistry?
What is the structure of the Japan immunohistochemistry market and who are the key players?
What is the degree of competition in the Japan immunohistochemistry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Immunohistochemistry Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Primary Antibodies
  - 6.1.3.2 Secondary Antibodies
- 6.1.4 Market Forecast (2025-2033)
6.2 Equipment
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Slide Staining Systems
  - 6.2.3.2 Tissue Microarrays
  - 6.2.3.3 Tissue Processing Systems
  - 6.2.3.4 Slide Scanners
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2025-2033)
6.3 Reagents
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Histological Stains
  - 6.3.3.2 Blocking sera and Reagents
  - 6.3.3.3 Chromogenic Substrates
  - 6.3.3.4 Fixation Reagents
  - 6.3.3.5 Stabilizers
  - 6.3.3.6 Organic Solvents
  - 6.3.3.7 Proteolytic Enzymes
  - 6.3.3.8 Diluents
- 6.3.4 Market Forecast (2025-2033)
6.4 Kits
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)

7 Japan Immunohistochemistry Market - Breakup by Application

7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Cancer
  - 7.1.3.2 Infectious Diseases
  - 7.1.3.3 Cardiovascular Diseases
  - 7.1.3.4 Autoimmune Diseases
  - 7.1.3.5 Diabetes Mellitus
  - 7.1.3.6 Nephrological Diseases
- 7.1.4 Market Forecast (2025-2033)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Immunohistochemistry Market - Breakup by End User

8.1 Hospitals and Diagnostic Laboratories
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2019-2024)
- 8.3.2 Market Forecast (2025-2033)

9 Japan Immunohistochemistry Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Immunohistochemistry Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis